The Experts in Animal Health

Brakke Consulting’s
Animal Health News & Notes for November 23, 2022
Copyright © Brakke Consulting
Editor: Lynn Fondon DVM MBA


Earnings News
Central Garden & Pet
J.M. Smucker

Other News
Biogénesis Bagó
Ceres Tag


  • The M. Smucker Co. announced results for the second quarter ended October 31, 2022, of its 2023 fiscal year. Pet Food segment sales were $765 million, a year-over-year increase of 9%. Excluding noncomparable net sales in the prior year related to the divested private label dry pet food business, net sales increased 14%. Segment profit was $120.1 million, an increase of 21%. (Seekingalpha)
  • Central Garden & Pet Company announced results for its fiscal year 2022 ended September 24, 2022. Net sales for the Pet segment were $1.88 billion, a decrease of 1% compared to a year ago. Income from operations for the Pet segment was $208.9 million, flat compared to the prior year. (company press release)
  • ImmuCell Corporation announced its unaudited financial results for the third quarter of 2022. Total unaudited sales were $4.80 million, a decrease of 7% compared to the prior-year period. Net operating loss was $(617,000) in contrast to a net operating income of $271,000 during the quarter ended September 30, 2021. (company press release)


  • Biogénesis Bagó announced it has acquired Spanish biotech HIPRA‘s line of hormone products. The deal allows Biogénesis Bagó to strengthen its portfolio and begin commercial operations in Europe. Financial terms were not disclosed. (PRnewswire)
  • AUSTRALIA Ceres Tag announced the launch of the “Ceres Ranch” tag, a reusable satellite smart ear tag. Communicating direct to satellite up to four times a day, livestock producers can get information on not only the GPS location of their animals but also their health and activity, as well as providing immediate mortality and boundary alerts. (Beefcentral)


  • US – ADUFA The FDA announced it will hold a virtual public meeting on December 7, 2022, to offer opportunity for comment on the proposed recommendations for reauthorization of the Animal Drug User Fee Act (ADUFA). Stakeholders interested in attending this public meeting must register online no later than December 5, 2022. Interested parties can share their comments at the meeting or by submitting them to the public docket electronically or by mail. (FDA)
  • US – MEAT SUBSTITUTES The FDA announced it has completed its first pre-market consultation for a human food made from cultured animal cells. UPSIDE Foods will use animal cell culture technology to take living cells from chickens and grow the cells in a controlled environment to make the cultured animal cell food. The FDA stated that “the voluntary pre-market consultation is not an approval process. Instead, it means that after our careful evaluation of the data and information shared by the firm, we have no further questions at this time about the firm’s safety conclusion.” In addition to meeting the FDA’s requirements, including facility registration for the cell culture portion of the process, the firm will need a grant of inspection from the USDA Food Safety and Inspection Service (USDA-FSIS) for the manufacturing establishment. Additionally, the food itself requires a mark of inspection from USDA-FSIS before it can enter the U.S. market. (FDA)


This is a short work week for most of us in the United States, and the beginning of the holiday season for all of us. We all have a lot to be thankful for, especially the people in our industry that provide for the health of our companion animals and feed our nation and the world.

We at Brakke Consulting wish a Happy Thanksgiving to all our clients and newsletter readers.

Bob Jones
Ron Brakke
Joel Adamson
Paul Casady
Cary Christensen
Lynn Fondon
Randy Freides
Jim Kroman
Jay Lockhart
John Mannhaupt
Amanda McDavid
Mike McGinley

Jeff Santosuosso
Kevin Scott
Jishu Shi
Yuki Ujimasa
John Volk

en_USEnglish (United States)